MENU
+Compare
UBX
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$1.00
Change
+$0.01 (+1.01%)
Capitalization
16.56M

UBX Unity Biotechnology Forecast, Technical & Fundamental Analysis

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging... Show more

Industry: #Biotechnology
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for UBX with price predictions
Apr 23, 2025

UBX sees its Stochastic Oscillator ascends from oversold territory

On April 11, 2025, the Stochastic Oscillator for UBX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UBX's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on UBX as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UBX just turned positive on April 14, 2025. Looking at past instances where UBX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBX advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

UBX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for UBX entered a downward trend on April 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.550) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. UBX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UBX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a r&d company of therapeutics to extend the human healthspan

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
285 East Grand Avenue
Phone
+1 650 416-1192
Employees
32
Web
https://www.unitybiotechnology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KIND1.450.04
+2.84%
Nextdoor Holdings
BIVI0.840.02
+2.48%
BioVie Inc
CPAY314.576.80
+2.21%
Corpay
SLG53.550.55
+1.04%
SL Green Realty Corp
TSQ6.80-0.05
-0.73%
Townsquare Media

UBX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UBX has been loosely correlated with NCNA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UBX
1D Price
Change %
UBX100%
+0.51%
NCNA - UBX
42%
Loosely correlated
+14.09%
JSPR - UBX
33%
Loosely correlated
+4.12%
ASMB - UBX
33%
Poorly correlated
+3.38%
ORMP - UBX
33%
Poorly correlated
+0.66%
MNMD - UBX
32%
Poorly correlated
+5.00%
More